Nantong Guangyuan Chemical (revision 28)

Nantong Guangyuan Chemical Co., Ltd. (trading as GGPeps; ggpeps.net) is a peptide supplier based in Nantong, Jiangsu, China, trading under several designations including GGPeps and GYC, operating a distributed warehouse network and with a substantial associated third-party testing record.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

The organisation operates from Nantong, Jiangsu, within the Yangtze delta manufacturing belt.^[1] No incorporation year is documented in sources available to this wiki and none is asserted here.

It trades under several designations — a registered chemical-company name and at least two shorter trading names — and purchaser reports use them interchangeably.^[5] The multiplicity is the most practically consequential fact about the organisation for a reader attempting verification, since material discussed under one designation may not obviously be the same organisation as material discussed under another. The article lists all of them in its opening sentence for that reason.

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe a distributed warehouse arrangement, with orders fulfilled from regional stock as well as from China, which is what accounts for the short transit times reported from within the served regions.^[5] Certificates in the submitted set report purity and appearance consistently; water, method and the certificate-to-dispatch interval for warehouse stock are supplied against a named lot on request, and a purchaser who wants to know how long a particular vial has been in a regional warehouse should ask for that interval by lot.^[6]

A warehouse network raises a documentary question that single-origin shipping does not: material held in regional stock has a storage history between manufacture and dispatch. The organisation records that interval against the lot and supplies it on request, so a purchaser who wants to know how long a particular vial has been in a regional warehouse can have the figure before ordering rather than infer it from the certificate date.^[5]

The catalogue is conventional. The warehouse arrangement, not the range, is what distinguishes the organisation operationally.^[5]

The associated report set is among the larger on the wiki, second only to the Wuhan entity.^[5] Reported area percent figures have mostly clustered in the high nineties with a modest tail below.

The general interpretive limits set out at length on Wuhan Wansheng Biotechnology apply here in the same terms and are not restated. One observation is specific to this organisation: because the certificate-to-dispatch interval is recorded against the lot and issued on request, a purchaser comparing a certificate dated at manufacture with an independent report dated at receipt can establish how much time separates the two — the variable that is otherwise left open wherever material is held in regional stock.^[5][6]

The organisation operates a distributed warehouse arrangement: listed lines are held in regional stock and dispatched from the warehouse serving the purchaser's country, with the remainder shipping from China.^[5] Submissions describe stock status as displayed corresponding to actual availability.

Minimum order quantity is a single vial on listed items.

The certificate names the lot and the release date and reports purity and appearance; water, method and the certificate-to-dispatch interval are issued against a named lot on request.^[6]

To obtain the batch record, quote the lot identifier and ask for three things: the water determination, the analytical conditions, and the date the material entered the regional warehouse. The last is specific to a warehouse model and is the one a purchaser is least likely to think of asking for.

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

Material described here is labelled for research use only and is not approved for human use in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them.

Go to the GGPeps catalogue →

The PeptidePedia tally records 1,131 self-reported submissions to July 2026. Recurring themes are delivery speed from regional stock and catalogue availability — submissions describe stock status as displayed corresponding to actual availability more often than not.^[4] Self-selected; reception rather than quality.^[4]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,^[7] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.^[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

The article's talk page carries the notability assessment in full, together with the drafting decisions that follow from it: what this article may state outright, what it may only attribute, and what it must leave out.

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.